Sam Myers, Ph.D.
Sam Myers is a research scientist II in the Proteomics Platform at the Broad Institute of MIT and Harvard. He joined the Broad Institute in 2014 as a postdoc in the laboratories of Steve Carr and Aviv Regev. Myers develops and applies interdisciplinary experimental and computational approaches to understand how signal transduction pathways integrate into transcriptional machinery to control gene expression during cell state transitions. His research combines mass spectrometry-based proteomics with chemical biology and genome engineering tools to dissect the various signaling modalities (phosphorylation, O-GlcNAcylation, ROS signaling, etc.) and dynamic protein complexes that control cellular differentiation and immune cell activation.
Myers received his B.S. in biochemistry from Cal Poly San Luis Obispo and his Ph.D. in chemistry and chemical biology from University of California, San Francisco. He will be joining La Jolla Institute for Immunology as an assistant professor in mid-2021